National Institutes of Health – Pharmacogenomics Research Network (U01/U19) Grant

Opportunity ID: 45085

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-GM-10-001
Funding Opportunity Title: Pharmacogenomics Research Network (U01/U19)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.209 — Contraception and Infertility Research Loan Repayment Program
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jan 30, 2009
Last Updated Date:
Original Closing Date for Applications: Jun 02, 2009
Current Closing Date for Applications: Jun 02, 2009
Archive Date: Jul 03, 2009
Estimated Total Program Funding: $30,000,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Private institutions of higher education
For profit organizations other than small businesses
Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following:
Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs).

Additional Information

Agency Name: National Institutes of Health
Description: Purpose. The purpose of this funding opportunity announcement issued by NIGMS, NHLBI, NCI, NIDA, NIMH, and NICHD is to allow new and renewal applications for research groups to compete to become part of the Pharmacogenomics Research Network (PGRN), and to create network resources that serve the entire PGRN. The PGRN is a consortium of interdisciplinary groups with a core mission to conduct research into understanding the genetic basis of variable drug responses, both therapeutic and adverse. The scientific objectives of the research network include definition of the pressing problems for safe and effective use of medications, establishment of truly cross-disciplinary research groups, application of the most appropriate genetic and genomic methods to important sample collections, discovery and replication studies that identify variation in critical genes and biological pathways, elucidation of the functional consequences of genetic variation for the drugs being studied, and understanding the clinical implications of genotyping to predict drug responses
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-GM-10-001.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *